Primiano Christopher Brett 4
4 · Karyopharm Therapeutics Inc. · Filed Nov 4, 2020
Insider Transaction Report
Form 4
Primiano Christopher Brett
VP, Gen Counsel & Secretary
Transactions
- Sale
Common Stock
2020-11-02$14.92/sh−772$11,518→ 4,523 total
Footnotes (2)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]Includes 646 shares acquired by the reporting person under the Karyopharm Therapeutics Inc. 2013 Employee Stock Purchase Plan on October 31, 2020.